1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cardiac Point of Care Testing (POCT) Analyzer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cardiac Point of Care Testing (POCT) Analyzer by Country/Region, 2018, 2022 & 2029
2.2 Cardiac Point of Care Testing (POCT) Analyzer Segment by Type
2.2.1 Benchtop
2.2.2 Portable
2.3 Cardiac Point of Care Testing (POCT) Analyzer Sales by Type
2.3.1 Global Cardiac Point of Care Testing (POCT) Analyzer Sales Market Share by Type (2018-2023)
2.3.2 Global Cardiac Point of Care Testing (POCT) Analyzer Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cardiac Point of Care Testing (POCT) Analyzer Sale Price by Type (2018-2023)
2.4 Cardiac Point of Care Testing (POCT) Analyzer Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Cardiac Point of Care Testing (POCT) Analyzer Sales by Application
2.5.1 Global Cardiac Point of Care Testing (POCT) Analyzer Sale Market Share by Application (2018-2023)
2.5.2 Global Cardiac Point of Care Testing (POCT) Analyzer Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cardiac Point of Care Testing (POCT) Analyzer Sale Price by Application (2018-2023)
3 Global Cardiac Point of Care Testing (POCT) Analyzer by Company
3.1 Global Cardiac Point of Care Testing (POCT) Analyzer Breakdown Data by Company
3.1.1 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Sales by Company (2018-2023)
3.1.2 Global Cardiac Point of Care Testing (POCT) Analyzer Sales Market Share by Company (2018-2023)
3.2 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Revenue by Company (2018-2023)
3.2.1 Global Cardiac Point of Care Testing (POCT) Analyzer Revenue by Company (2018-2023)
3.2.2 Global Cardiac Point of Care Testing (POCT) Analyzer Revenue Market Share by Company (2018-2023)
3.3 Global Cardiac Point of Care Testing (POCT) Analyzer Sale Price by Company
3.4 Key Manufacturers Cardiac Point of Care Testing (POCT) Analyzer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiac Point of Care Testing (POCT) Analyzer Product Location Distribution
3.4.2 Players Cardiac Point of Care Testing (POCT) Analyzer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cardiac Point of Care Testing (POCT) Analyzer by Geographic Region
4.1 World Historic Cardiac Point of Care Testing (POCT) Analyzer Market Size by Geographic Region (2018-2023)
4.1.1 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cardiac Point of Care Testing (POCT) Analyzer Market Size by Country/Region (2018-2023)
4.2.1 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cardiac Point of Care Testing (POCT) Analyzer Sales Growth
4.4 APAC Cardiac Point of Care Testing (POCT) Analyzer Sales Growth
4.5 Europe Cardiac Point of Care Testing (POCT) Analyzer Sales Growth
4.6 Middle East & Africa Cardiac Point of Care Testing (POCT) Analyzer Sales Growth
5 Americas
5.1 Americas Cardiac Point of Care Testing (POCT) Analyzer Sales by Country
5.1.1 Americas Cardiac Point of Care Testing (POCT) Analyzer Sales by Country (2018-2023)
5.1.2 Americas Cardiac Point of Care Testing (POCT) Analyzer Revenue by Country (2018-2023)
5.2 Americas Cardiac Point of Care Testing (POCT) Analyzer Sales by Type
5.3 Americas Cardiac Point of Care Testing (POCT) Analyzer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiac Point of Care Testing (POCT) Analyzer Sales by Region
6.1.1 APAC Cardiac Point of Care Testing (POCT) Analyzer Sales by Region (2018-2023)
6.1.2 APAC Cardiac Point of Care Testing (POCT) Analyzer Revenue by Region (2018-2023)
6.2 APAC Cardiac Point of Care Testing (POCT) Analyzer Sales by Type
6.3 APAC Cardiac Point of Care Testing (POCT) Analyzer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cardiac Point of Care Testing (POCT) Analyzer by Country
7.1.1 Europe Cardiac Point of Care Testing (POCT) Analyzer Sales by Country (2018-2023)
7.1.2 Europe Cardiac Point of Care Testing (POCT) Analyzer Revenue by Country (2018-2023)
7.2 Europe Cardiac Point of Care Testing (POCT) Analyzer Sales by Type
7.3 Europe Cardiac Point of Care Testing (POCT) Analyzer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiac Point of Care Testing (POCT) Analyzer by Country
8.1.1 Middle East & Africa Cardiac Point of Care Testing (POCT) Analyzer Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cardiac Point of Care Testing (POCT) Analyzer Revenue by Country (2018-2023)
8.2 Middle East & Africa Cardiac Point of Care Testing (POCT) Analyzer Sales by Type
8.3 Middle East & Africa Cardiac Point of Care Testing (POCT) Analyzer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiac Point of Care Testing (POCT) Analyzer
10.3 Manufacturing Process Analysis of Cardiac Point of Care Testing (POCT) Analyzer
10.4 Industry Chain Structure of Cardiac Point of Care Testing (POCT) Analyzer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiac Point of Care Testing (POCT) Analyzer Distributors
11.3 Cardiac Point of Care Testing (POCT) Analyzer Customer
12 World Forecast Review for Cardiac Point of Care Testing (POCT) Analyzer by Geographic Region
12.1 Global Cardiac Point of Care Testing (POCT) Analyzer Market Size Forecast by Region
12.1.1 Global Cardiac Point of Care Testing (POCT) Analyzer Forecast by Region (2024-2029)
12.1.2 Global Cardiac Point of Care Testing (POCT) Analyzer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cardiac Point of Care Testing (POCT) Analyzer Forecast by Type
12.7 Global Cardiac Point of Care Testing (POCT) Analyzer Forecast by Application
13 Key Players Analysis
13.1 LSI Medience Corporation
13.1.1 LSI Medience Corporation Company Information
13.1.2 LSI Medience Corporation Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.1.3 LSI Medience Corporation Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 LSI Medience Corporation Main Business Overview
13.1.5 LSI Medience Corporation Latest Developments
13.2 CardioGenics
13.2.1 CardioGenics Company Information
13.2.2 CardioGenics Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.2.3 CardioGenics Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CardioGenics Main Business Overview
13.2.5 CardioGenics Latest Developments
13.3 Trinity Biotech
13.3.1 Trinity Biotech Company Information
13.3.2 Trinity Biotech Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.3.3 Trinity Biotech Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Trinity Biotech Main Business Overview
13.3.5 Trinity Biotech Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.4.3 Abbott Laboratories Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Boditech
13.5.1 Boditech Company Information
13.5.2 Boditech Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.5.3 Boditech Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Boditech Main Business Overview
13.5.5 Boditech Latest Developments
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Information
13.6.2 Beckman Coulter Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.6.3 Beckman Coulter Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beckman Coulter Main Business Overview
13.6.5 Beckman Coulter Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.7.3 Roche Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Siemens Healthcare
13.8.1 Siemens Healthcare Company Information
13.8.2 Siemens Healthcare Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.8.3 Siemens Healthcare Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Siemens Healthcare Main Business Overview
13.8.5 Siemens Healthcare Latest Developments
13.9 Lifesign
13.9.1 Lifesign Company Information
13.9.2 Lifesign Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.9.3 Lifesign Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lifesign Main Business Overview
13.9.5 Lifesign Latest Developments
13.10 Response Biomedical
13.10.1 Response Biomedical Company Information
13.10.2 Response Biomedical Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.10.3 Response Biomedical Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Response Biomedical Main Business Overview
13.10.5 Response Biomedical Latest Developments
13.11 Diadama
13.11.1 Diadama Company Information
13.11.2 Diadama Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.11.3 Diadama Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Diadama Main Business Overview
13.11.5 Diadama Latest Developments
13.12 Getein Biotechnology
13.12.1 Getein Biotechnology Company Information
13.12.2 Getein Biotechnology Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.12.3 Getein Biotechnology Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Getein Biotechnology Main Business Overview
13.12.5 Getein Biotechnology Latest Developments
13.13 Quidel
13.13.1 Quidel Company Information
13.13.2 Quidel Cardiac Point of Care Testing (POCT) Analyzer Product Portfolios and Specifications
13.13.3 Quidel Cardiac Point of Care Testing (POCT) Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Quidel Main Business Overview
13.13.5 Quidel Latest Developments
14 Research Findings and Conclusion
| ※参考情報 心臓用POCT分析装置は、心臓病の迅速な診断と管理を目的とした医療機器であり、その特徴や用途、関連技術について詳しく述べます。 POCT（Point of Care Testing）とは、患者の近くで直接行われる診断検査を指します。これに対して心臓用POCT分析装置は、心疾患に関連する生理的な指標やバイオマーカーを測定するために設計された特化型の装置です。これらの装置は、緊急の状況や病院外の環境で利用されることが多く、迅速な結果を提供することが求められます。 心臓疾患は、世界的に見ても主要な死因の一つであり、その早期発見と迅速な治療が重要です。心臓用POCT分析装置は、心筋梗塞、心不全、狭心症などの急性および慢性の心疾患を迅速に評価することが可能です。一般的には、血液サンプルを用いた検査が行われます。このような検査により、特定のバイオマーカーの濃度を測定し、診断や治療方針の決定に資する情報を提供します。 心臓用POCT分析装置の特徴としては、速さ、簡便さ、高精度などが挙げられます。まず速さについてですが、通常の検査室での検査は、サンプルを分析するまでに時間がかかることがあります。しかし、POCTでは患者サイドで即座に測定が行われ、数分から数十分で結果が得られます。この迅速性は、急性心疾患の治療において非常に重要で、迅速な判断が生死を分けることもあります。 次に簡便さについてですが、これらの装置は操作が比較的容易であり、専門的な訓練を受けた医療従事者以外でも使用が可能なことが多いです。これにより、地域のクリニックや救急医療の現場でも導入されやすく、多くの患者に対してアクセス可能な医療を提供することが可能になります。また、コンパクトなデザインであるため、持ち運びが簡単であり、さまざまな環境での使用が期待されます。 高精度についても重要な要素です。心臓用POCT分析装置は、臨床検査室で行うような高精度な測定を目指しており、各種の臨床的な要件を満たすように設計されています。これにより、診断の信頼性が高まり、医療現場での意思決定を支援します。 心臓用POCT分析装置にはいくつかの種類があります。代表的なものには、心筋トロポニン測定装置、BNP（B型ナトリウム利尿ペプチド）測定装置、CK-MB（クレアチンキナーゼ-MB）測定装置などがあります。これらはそれぞれ異なる指標を測定し、心疾患の種類や重症度を評価するために用いられます。 心筋トロポニンは心筋の損傷を示す重要なバイオマーカーであり、心筋梗塞の診断に特に有用です。トロポニン値の上昇は心筋細胞の損傷を示すため、早期の診断と治療に役立ちます。BNPは心不全の指標として広く使われており、心不全の重症度を評価するための重要な情報を提供します。CK-MBも心筋損傷の指標として使用されますが、他のバイオマーカーと併せて利用されることが多いです。 心臓用POCT分析装置の用途は多岐にわたります。緊急医療、救急外来、普段の診療所でのフォローアップ、さらには高齢者医療や慢性疾患管理などでの使用が考えられます。特に救急外来においては、患者の状態を迅速に評価するための重要なツールです。心疾患の疑いがある患者の早期評価や治療を行うことで、合併症のリスクを減少させることが可能です。 関連技術としては、バイオセンサー技術、ナノテクノロジー、マイクロ流体技術などが挙げられます。これらの技術は、POCT分析装置の精度や感度を向上させるためのものであり、より迅速で正確な測定が可能となります。バイオセンサー技術は、特定のバイオマーカーを高感度で検出することができるため、心疾患の早期發見に寄与します。ナノテクノロジーにより、検出器のサイズを小型化しつつ、機能性を高めることが可能です。マイクロ流体技術は、サンプルの取り扱いや分離を効率化し、結果として検査のスピードと精度を向上させます。 最近では、AI（人工知能）や機械学習を活用したデータ解析技術も注目されています。心臓用POCT分析装置から得られたデータをAIがリアルタイムで分析し、より正確な診断や予測を行うことが可能となります。これにより、医療従事者の負担を軽減し、より質の高い医療提供が実現することを期待されています。 心臓用POCT分析装置は、急増する心疾患の診断・治療において、その重要性を増しており、医療現場での活用が進むにつれ、さらに進化を遂げていくことでしょう。今後の技術革新とともに、これらの装置がより多くの患者に恩恵をもたらすことが期待されます。心疾患に対する理解を深め、新たな診断・治療の可能性を開くために、心臓用POCT分析装置の役割はますます重要になるといえるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
